Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Reliability of the gamma index analysis as a verification method of volumetric modulated arc therapy plans

Fig. 1

Global gamma passing rates of the VMAT plans. Global gamma passing rates with various gamma criteria calculated from the measurements with the MapCHECK2 dosimeter are shown for Trilogy (a) and TrueBeam STx (c). Those with the ArcCHECK dosimeter using Trilogy (b) and TrueBeam STx (d) are also shown. For the global gamma passing rates with Trilogy, the H&N plans, prostate primary plans (PPs), prostate boost plans (BPs), liver plans, and spine plans were analyzed, while the lung SABR, spine SABR, liver SABR, brain, and H&N plans were analyzed with TrueBeam STx

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us